Hultquist, PLLC
Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same
The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.
PharmAbcine Inc.
C C A A C C C C C A A C C A G A C C C G
C07K C07K A61P A61P C07K C07K C07K C07K C07K A61P A61P C07K C07K A61P G01N A61P C07K C07K C07K G01N
inventional inventional inventional inventional additional additional additional additional additional inventional inventional additional additional inventional inventional inventional inventional additional additional additional
Sang Hoon Jae Bong Do Yun Yeun Ju In Sook Sung Woo Hyuk Joon Nam Ye Jong Geun Seon Hwan Eun Jin Jin Sook Jin Sang Bo Young Sang Soon Joong Kyu Mi Ju Seon Young Jin Hee Jin San Weon Sup Ju Ryung Young Ae Sang Ryeol Kyung Hee
Lee Yoon Kim Kim Park Kim Lee Kim Jeong Oh Lee Lee Yoo Jeong Byun Kim Park Lee Choi Yoo Lee Nam Lee Shim Nahm